Research Areas

In this section, by  far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.

15 Item(s)

per page
Axon ID Name Description From price
3748 C-82 Specific inhibitor of Wnt/β-catenin signaling pathway €110.00
1442 Caprospinol Alzheimer's disease therapeutic and antihistaminergic drug €110.00
2161 CCT 031374 hydrobromide Inhibitor of TCF-dependent transcription of genes of Wnt signaling pathway €60.00
3715 E-7386 CBP/beta-catenin modulator Inquire
1766 ICG 001 Specific inhibitor of Wnt/β-catenin signaling pathway €115.00
2135 iCRT14 Small-molecule inhibitor of the Wnt/wingless signaling pathway; CRT inhibitor €135.00
2133 iCRT5 β-Catenin-responsive transcription (CRT) inhibitor €80.00
3948 ISX9 Wnt/β-catenin signaling pathway agonist €110.00
2378 Kartogenin Promotor of chondrocyte differentiation from primary human MSCs €75.00
3342 MSAB Potent and selective inhibitor of Wnt/β-catenin signaling pathway €80.00
3152 PAWI-2 Inhibitor which targets both Wnt signaling and ATM/p53 €120.00
3749 PRI-724 Specific inhibitor of Wnt/β-catenin signaling pathway €190.00
2084 SKL 2001 Wnt/β-catenin signaling pathway agonist or activator €90.00
2481 SMT C1100 Orally active, non-toxic upregulator of utrophin production €125.00
2120 Wnt agonist 1 Wnt/β-catenin signaling pathway agonist or activator €90.00

15 Item(s)

per page
Please wait...